0808 801 email@example.com
07860 058 830
This edition looks at our inspiring London Marathon team, our new gynae sarcoma report and how your donations fund
GIST drug regorafenib remains on the Cancer Drugs Fund approved list, pending t
Our chief executive, Lindsey Bennister calls for urgent reform of European legislation by acting as a signatory to a sector-wide letter in today's Telegraph.
The National Cancer Patient Conference is a chance for cancer patients to speak out and help develop cancer services across the country.
The National Institute for Health and Care Excellence (NICE) has launched a new sarcoma quality standard, covering the diagnosis, treatment, support and follow-up of sa
Are you someone who is passionate about admin and wants to work within a fast-growing and developing national cance
'Soft tissue sarcoma – a clinical update' event at The Royal Marsden.
Wednesday 8 July.
The research allocation for the 2015 grant round is £350k.
Capital C is a collaboration to improve cancer care for the people of London, and they want to hear from anyone aff
Three sarcoma drugs are now unavailable to new patients following a major review of the Cancer Drugs Fund.